Soleno Therapeutics, Inc. · NASDAQ:SLNO

T. Rowe Price Associates Inc reported a 6.90% stake in Soleno Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2025 · Filed Aug 14, 2025

T. Rowe Price Associates Inc reported a 6.90% stake in Soleno Therapeutics, Inc., 3,461,510 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).

Stake
6.90%
Shares
3,461,510
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
T. Rowe Price Associates, Inc.6.90%3,461,510

Source

View original at SEC

Related